Home/Filings/4/0001213900-25-087374
4//SEC Filing

Todisco Joseph 4

Accession 0001213900-25-087374

CIK 0001410098other

Filed

Sep 11, 8:00 PM ET

Accepted

Sep 12, 9:45 PM ET

Size

9.0 KB

Accession

0001213900-25-087374

Insider Transaction Report

Form 4
Period: 2025-09-12
Todisco Joseph
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-09-12$3.47/sh+50,000$173,500559,496 total
  • Exercise/Conversion

    Stock Option (Right to Buy Common Stock)

    2025-09-1250,000216,667 total
    Exercise: $3.47Exp: 2034-01-11Common Stock (50,000 underlying)
  • Sale

    Common Stock

    2025-09-12$13.00/sh50,000$650,000509,496 total
Footnotes (2)
  • [F1]This transaction was executed in multiple trades at prices ranging from $12.82 to $13.27. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
  • [F2]These options were granted on 01/12/2024. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

Documents

1 file

Issuer

CorMedix Inc.

CIK 0001410098

Entity typeother

Related Parties

1
  • filerCIK 0001774807

Filing Metadata

Form type
4
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 9:45 PM ET
Size
9.0 KB